EP3140008
Hraðvirkar insúlínsamsetningar
Status:
EP einkaleyfi í gildi á ÍslandiEP appl. date:
4.5.2015EP published:
17.4.2019EP application number:
15723388.3
EP translation filed:
7.5.2019Grant published:
15.6.2019EPO information:
European Patent Register
Max expiry date:
3.5.2035Expiry date:
3.5.2026Next due date:
31.5.2026
Title:
RAPID-ACTING INSULIN COMPOSITIONS
Timeline
Today
4.5.2015EP application
17.4.2019EP Publication
7.5.2019Translation submitted
15.6.2019Registration published
3.5.2026Expires
Owner
Name:
Eli Lilly and CompanyAddress:
Lilly Corporate Center, 46285, Indianapolis, IN, US
Inventor
Name:
CHRISTE, Michael EdwardAddress:
Indianapolis, Indiana, US
Name:
HARDY, Thomas AndrewAddress:
Indianapolis, Indiana, US
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113, Reykjavík,
Priority
Number:
201461990402 PDate:
8.5.2014Country:
US
Classification
Categories:
A61P 3/10, A61K 38/28, A61K 31/5585
Annual fees
Number
Paid
Expires
Payer
Number: 5
Paid: 23.5.2019
Expires: 3.5.2020
Payer: Árnason Faktor
Number: 6
Paid: 14.4.2020
Expires: 3.5.2021
Payer: Örn Þór slf.
Number: 7
Paid: 21.4.2021
Expires: 3.5.2022
Payer: Patice ehf.
Number: 8
Paid: 19.4.2022
Expires: 3.5.2023
Payer: Patice ehf.
Number: 9
Paid: 22.4.2023
Expires: 3.5.2024
Payer: Árnason Faktor ehf.
Number: 10
Paid: 19.4.2024
Expires: 3.5.2025
Payer: Árnason Faktor ehf.
Number: 11
Paid: 5.5.2025
Expires: 3.5.2026
Payer: Árnason Faktor ehf.